Panniculitis does not predict clinical response in patients with advanced melanoma under targeted therapy

被引：0
|
作者：
Marie Piroth
Thomas Goronflot
Romain Samaran
Emilie Varey
Alexandra Poinas
Amir Khammari
Brigitte Dreno
机构：
[1] Nantes Université,CHU Nantes Service de Dermatologie, Hôtel
[2] Nantes Université,Dieu, Nantes
[3] Hôpital du Mans,CHU Nantes, Pôle Hospitalo
[4] Nantes Université,Universitaire 11: Santé Publique, Clinique des données, INSERM, CIC 1413
[5] Nantes Université,Service de Dermatologie
来源：
European Journal of Dermatology | 2023年 / 33卷
关键词：
BRAF inhibitor; MEK inhibitor; melanoma; oncology; panniculitis; targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：126 / 136
页数：10
相关论文
共 50 条
  • [21] Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland
    Mangana, Joanna
    Cheng, Phil F.
    Kaufmann, Corina
    Amann, Valerie C.
    Frauchiger, Anna L.
    Stoegner, Viola
    Held, Ulrike
    von Moos, Roger
    Michielin, Olivier
    Braun, Ralph P.
    Levesque, Mitchell P.
    Goldinger, Simone M.
    Dummer, Reinhard
    MELANOMA RESEARCH, 2017, 27 (04) : 358 - 368
  • [22] Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies
    Van Not, Olivier J.
    van den Eertwegh, Alfons J. M.
    Haanen, John B.
    van Rijn, Rozemarijn S.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Blank, Christian U.
    Boers-Sonderen, Marye J.
    van Eijs, Mick J. M.
    de Groot, Jan-Willem B.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    de Meza, Melissa
    Piersma, Djura
    Stevense-den Boer, Marion
    van der Veldt, Astrid A. M.
    Vreugdenhil, Gerard
    Wouters, Michel W. J. M.
    Suijkerbuijk, Karijn P. M.
    Blokx, Willeke A. M.
    EUROPEAN JOURNAL OF CANCER, 2023, 186 : 27 - 37
  • [23] Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma
    Simeone, Ester
    Grimaldi, Antonio Maria
    Festino, Lucia
    Giannarelli, Diana
    Vanella, Vito
    Palla, Marco
    Curvietto, Marcello
    Esposito, Assunta
    Palmieri, Giuseppe
    Mozzillo, Nicola
    Ascierto, Paolo Antonio
    ONCOIMMUNOLOGY, 2017, 6 (03):
  • [24] Hypertension does not influence response to EGFR targeted therapy in patients with advanced non-small-cell lung cancer
    Liu, Kejun
    Zhang, Weiwei
    Tan, Qinquan
    Jiang, Guanming
    Jia, Jun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (06): : 7609 - 7615
  • [25] Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?
    Schouwenburg, Maartje G.
    Suijkerbuijk, Karijn P. M.
    Koornstra, Rutger H. T.
    Jochems, Anouk
    van Zeijl, Michiel C. T.
    van den Eertwegh, Alfons J. M.
    Haanen, John B. A. G.
    Aarts, Maureen J. B.
    van Akkooi, Alexander C. J.
    van den Berkmortel, Franchette W. P. J.
    de Groot, Jan Willem B.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Kruit, Wim H.
    Piersma, Djura
    van Rijn, Rozemarijn S.
    ten Tije, Albert J.
    Vreugdenhil, Gerard
    van der Hoeven, Jacobus J. M.
    Wouters, Michel W. J. M.
    CANCERS, 2019, 11 (12)
  • [26] Targeted therapy followed by immunotherapy in a patient with advanced malignant melanoma
    Markiewicz-Bialek, Beata
    Bialek, Piotr
    Blasinska-Morawiec, Maria
    ONCOLOGY IN CLINICAL PRACTICE, 2018, 14 : A26 - A27
  • [27] Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor
    Nadja A. Galliker
    Carla Murer
    Jivko Kamarashev
    Reinhard Dummer
    Simone M. Goldinger
    European Journal of Dermatology, 2015, 25 : 177 - 180
  • [28] Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor
    Galliker, Nadja A.
    Murer, Carla
    Kamarashev, Jivko
    Dummer, Reinhard
    Goldinger, Simone M.
    EUROPEAN JOURNAL OF DERMATOLOGY, 2015, 25 (02) : 177 - 180
  • [29] Genes Involved in Immune Reinduction May Constitute Biomarkers of Response for Metastatic Melanoma Patients Treated with Targeted Therapy
    Berciano-Guerrero, Miguel-Angel
    Lavado-Valenzuela, Rocio
    Moya, Aurelio
    delaCruz-Merino, Luis
    Toscano, Fatima
    Valdivia, Javier
    Castellon, Victoria
    Henao-Carrasco, Fernando
    Sancho, Pilar
    Onieva-Zafra, Juan-Luis
    Navas-Delgado, Ismael
    Rueda-Dominguez, Antonio
    Perez-Ruiz, Elisabeth
    Alba, Emilio
    BIOMEDICINES, 2022, 10 (02)
  • [30] Cessation of targeted therapy after a complete response in BRAF-mutant advanced melanoma: a case series
    Carlino, Matteo S.
    Vanella, Vito
    Girgis, Christina
    Giannarelli, Diana
    Guminski, Alex
    Festino, Lucia
    Kefford, Richard F.
    Menzies, Alexander M.
    Long, Georgina V.
    Ascierto, Paolo A.
    BRITISH JOURNAL OF CANCER, 2016, 115 (11) : 1280 - 1284
12345